Markets plunged more than 670 points, logging the worst week in 2 years. Lindsey Bell, Investment Strategist at CFRA Research, was with us to break down the factors causing stocks to tumble. A positive jobs report that revealed 200,000 jobs in January and a 2.9% increase in wages are giving the Fed more ammo in its case to raise rates at a faster pace. It's not just rates that are a cause of concern, said Bell. The analyst said we are seeing China had a tough week over concerns over economic growth and financial regulation. Bell said we also can't underestimate the impact the release of the GOP surveillance document had on the markets. This is a form of uncertainty, which could lead to investors pulling money out of the markets, she added. Bell said she thinks this is a healthy move downward and profit-taking is probably necessary. She said a 10% pullback could be in the cards.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More